A Non-Invasive Neuromodulation Device for Prevention of Episodic Migraine Headache
Status: Terminated
Location: See all (10) locations...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
This study will assess the efficacy of a neuromodulation device for the treatment of episodic migraine headache.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 65
Healthy Volunteers: f
View:
• diagnosed with episodic migraine at least 6 months before study
• at least 3 consecutive months of stable migraine headaches before study
• at least 4-14 headache days per month, of which 4-14 may be migraines
• must not have failed on more than 2 classes of migraine preventatives
Locations
United States
Arizona
Mayo Clinic
Scottsdale
Florida
Neurology Research Institute
West Palm Beach
Illinois
Diamond Headache Clinic
Chicago
Michigan
Michigan Headache Pain & Neurological Inst.
Ann Arbor
Missouri
Study Metrix Research
Saint Peters
New Hampshire
Dartmouth-Hitchcock Medical Center
Lebanon
Ohio
Cleveland Clinic
Cleveland
Pennsylvania
Jefferson Headache Center
Philadelphia
Other Locations
United Kingdom
University of Kent
Canterbury
King's College London
London
Time Frame
Start Date: 2017-06-30
Completion Date: 2018-05-11
Participants
Target number of participants: 45
Treatments
Active_comparator: active
active neuromodulation
Placebo_comparator: placebo
placebo neuromodulation
Authors
Sponsors
Leads: Scion NeuroStim